Trials / Completed
CompletedNCT06228911
Increased Blood Glucose Levels After Steroid Injection
Increased Blood Glucose Levels After Steroid Injection Into Osteoarthritic Knee in Diabetic Patients' Type 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (actual)
- Sponsor
- Syrian Private University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
a sample of 600 patients diagnosed as Knee osteoarthritis injected with 40 mg triamcinolone, recorded their morning fasting blood glucose levels for 7 days before injection used as the baseline blood glucose level, which was compared with FBS levels for 14 days after steroid injection. Our study compared the differences in blood glucose changes between HbA1c \>7% and HbA1c ≤7% groups and those between insulin and non-insulin treated groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | steroid (triamcinolone) | triamcinolone is a synthetic corticosteroid medication used topically to treat various skin conditions, to relieve the discomfort of mouth sores, and by injection into joints to treat various joint conditions |
Timeline
- Start date
- 2020-01-15
- Primary completion
- 2023-09-15
- Completion
- 2023-09-15
- First posted
- 2024-01-29
- Last updated
- 2024-01-30
Locations
1 site across 1 country: Syria
Source: ClinicalTrials.gov record NCT06228911. Inclusion in this directory is not an endorsement.